Health and Fitness Health and Fitness
Fri, July 6, 2012
[ Fri, Jul 06th 2012 ] - Market Wire
Avanir Pharmaceuticals To Present At The Seventh Annual JMP Securities Healthcare Conference
[ Fri, Jul 06th 2012 ] - Market Wire
Amica Mature Lifestyles to Announce Fourth Quarte .. Results and Host Conference Call August 13, 2012
[ Fri, Jul 06th 2012 ] - Market Wire
Equity Research on Sequenom Inc. and Biogen Idec .. otechnology Industry Taking the Good With the Bad
[ Fri, Jul 06th 2012 ] - Market Wire
Lilly Obtains Six Months U.S. Pediatric Exclusivity for Cymbalta (duloxetine HCl)
[ Fri, Jul 06th 2012 ] - Market Wire
ShangPharma Announces Receipt of quot;;Goi .. equot;; Proposal at $8.50 to $9.50 Per ADS
[ Fri, Jul 06th 2012 ] - Market Wire
Auxilium Pharmaceuticals, Inc. to Present At The JMP Securities 2012 Healthcare Conference
[ Fri, Jul 06th 2012 ] - Market Wire
Solta Medical to Present at the JMP Securities Healthcare Conference
[ Fri, Jul 06th 2012 ] - Market Wire
TheStockRadio.com Interviews Amarantus BioScience .. President amp;; CEO Gerald E. Commissiong
[ Fri, Jul 06th 2012 ] - Market Wire
Aoxing Pharmaceutical Company Announces Management Change
Thu, July 5, 2012
[ Thu, Jul 05th 2012 ] - Market Wire
Vanda Pharmaceuticals to Present at the JMP Securities Healthcare Conference
[ Thu, Jul 05th 2012 ] - Market Wire
Alexza Announces Adasuvea" (Staccato Loxapine) PDUFA Goal Date of December 21, 2012
[ Thu, Jul 05th 2012 ] - Market Wire
Transcept Pharmaceuticals to Present at the JMP Securities Healthcare Conference
[ Thu, Jul 05th 2012 ] - Market Wire
West Announces Completion of Private Placement of Senior Debt Securities
[ Thu, Jul 05th 2012 ] - Market Wire
NxStage to Report Second Quarter Fiscal 2012 Financial Results
[ Thu, Jul 05th 2012 ] - Market Wire
Amgen Completes Acquisition of KAI Pharmaceuticals
[ Thu, Jul 05th 2012 ] - Market Wire
Watson to Host Second Quarter 2012 Earnings Conference Call and Webcast
[ Thu, Jul 05th 2012 ] - Market Wire
Cytokinetics to Present at 7th Annual JMP Securities Healthcare Conference
[ Thu, Jul 05th 2012 ] - Market Wire
Cadence Pharmaceuticals To Present At The 7th Ann .. care Conference In New York City On July 12, 2012
[ Thu, Jul 05th 2012 ] - Market Wire
Extendicare Normal Course Issuer Bid Approved by TSX
[ Thu, Jul 05th 2012 ] - Market Wire
Sanford Wittels amp;; Heisler Files $100 M .. ion Class Action In Southern District Of New York
[ Thu, Jul 05th 2012 ] - Market Wire
Implant Sciences Described as "An Attractive Pure .. s Detection" in Gene Marcial's Blog on Forbes.com
[ Thu, Jul 05th 2012 ] - Market Wire
Leatt Corporation Becomes Fully Reporting Public Company
[ Thu, Jul 05th 2012 ] - Market Wire
Optimer Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
[ Thu, Jul 05th 2012 ] - Market Wire
Leading Independent Proxy Advisory Firm Glass, Le .. ds Stockholders Vote to Elect All of Mr. Choi's D
[ Thu, Jul 05th 2012 ] - Market Wire
Analyst Research on Health Management Associates .. p. -- Hospitals Profiting From Supreme Court Ruli
[ Thu, Jul 05th 2012 ] - Market Wire
Biotech Companies -- Led by Amgen and Celgene -- Increase R&;;D Spending in 2011
[ Thu, Jul 05th 2012 ] - Market Wire
DIFICIDa" (fidaxomicin), a first-in-class antibio .. o treat C. difficile, a serious and life-threaten
[ Thu, Jul 05th 2012 ] - Market Wire
Uroplasty To Present At The JMP Securities Healthcare Conference
[ Thu, Jul 05th 2012 ] - Market Wire
Arena Pharmaceuticals Promotes Craig M. Audet to .. ice President, Operations and Head of Global Regu
[ Thu, Jul 05th 2012 ] - Market Wire
Isis Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference

Isis Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference


Published on 2012-07-05 04:07:44 - Market Wire
  Print publication without navigation


Isis Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference -- CARLSBAD, Calif., July 5, 2012 /PRNewswire/ --

Isis Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference

[ ]

CARLSBAD, Calif., July 5, 2012 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: [ ISIS ]), the leader in antisense therapeutics, today announced that management will present a company overview at the 7th Annual JMP Securities Healthcare Conference on Thursday, July 12, 2012 at 2:00 p.m. ET at the Peninsula Hotel in New York.

A live audio webcast of the presentation will be available on the "Investors & Media" section of the Company's Web site, [ www.isispharm.com ].  A replay of the presentation will be available on the Isis Web site within 48 hours and will be archived for a limited time.

ABOUT ISIS PHARMACEUTICALS, INC. Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners.  Isis' broad pipeline consists of 25 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe and rare diseases, and cancer.  Isis' partner, Genzyme, plans to commercialize Isis' lead product, KYNAMRO, following regulatory approval, which is expected in 2012.  Isis' patents provide strong and extensive protection for its drugs and technology.  Additional information about Isis is available at [ www.isispharm.com ].

SOURCE Isis Pharmaceuticals, Inc.



[ Back to top ]

RELATED LINKS
[ http://www.isispharm.com ]

Contributing Sources